Just shot off a quick email to BDM on this exciting news:
For full note see SPL release to ASX 1.25pm 22/11/12.
Starpharma to recoup $6 million cash for OVERSEAS R&D
Melbourne, Australia: Starpharma (ASX:SPL; OTCQX:SPHRY) today announced that following a submission to AusIndustry, it is eligible to receive approximately $6 million cash in R&D tax incentive for OVERSEAS R&D activities.
Starpharma made a submission for an advance finding in relation to VivaGel® activities in June 2012, and AusIndustry has today notified the Company that its overseas R&D activities satisfy the required criteria under the 45% R&D Tax Incentive Program.
Could Biodiem profit from this program?
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
2.2¢ |
Change
0.000(0.00%) |
Mkt cap ! $31.26M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 448 | 2.2¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 2.4¢ | 388415 | 4 |
View Market Depth
| Last trade - 10.02am 15/09/2025 (20 minute delay) ? |
| BDM (ASX) Chart |
Day chart unavailable